613 related articles for article (PubMed ID: 25728094)
21. Hodgkin's disease-like lymphoproliferative disorders in patients with different underlying immunodeficiency states.
Tinguely M; Vonlanthen R; Müller E; Dommann-Scherrer CC; Schneider J; Laissue JA; Borisch B
Mod Pathol; 1998 Apr; 11(4):307-12. PubMed ID: 9578079
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Epstein-Barr virus association with pediatric non-hodgkin lymphoma in immunocompetent and in immunocompromised patients in Argentina.
Chabay PA; De Matteo EN; Aversa L; Maglio S; Grinstein S; Preciado MV
Arch Pathol Lab Med; 2002 Mar; 126(3):331-5. PubMed ID: 11860309
[TBL] [Abstract][Full Text] [Related]
23. Immunodeficiency-related Hodgkin lymphoma and its mimics.
Said JW
Adv Anat Pathol; 2007 May; 14(3):189-94. PubMed ID: 17452815
[TBL] [Abstract][Full Text] [Related]
24. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
Chiang AK; Tao Q; Srivastava G; Ho FC
Int J Cancer; 1996 Nov; 68(3):285-90. PubMed ID: 8903467
[TBL] [Abstract][Full Text] [Related]
25. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
Huck K; Feyen O; Niehues T; Rüschendorf F; Hübner N; Laws HJ; Telieps T; Knapp S; Wacker HH; Meindl A; Jumaa H; Borkhardt A
J Clin Invest; 2009 May; 119(5):1350-8. PubMed ID: 19425169
[TBL] [Abstract][Full Text] [Related]
26. Atypical Clinical Course in Pediatric Hodgkin Lymphoma: Association With Germline Mutations in Interleukin-2-inducible T-Cell Kinase.
Alme C; Satwani P; Alobeid B; Bhagat G; Kelly KM
J Pediatr Hematol Oncol; 2015 Oct; 37(7):507-8. PubMed ID: 26056787
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr virus-associated lymphomas.
Gandhi MK
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):77-89. PubMed ID: 16441211
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus-associated lymphoproliferative disorders.
Ambinder RF
Rev Clin Exp Hematol; 2003 Dec; 7(4):362-74. PubMed ID: 15129648
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-associated lymphoproliferative disorder presenting with classical Hodgkin lymphoma and developing as peripheral T-cell lymphoma 9 years later: a case report of composite lymphoma.
Oka K; Nagayama R; Iijima S; Yonekawa N; Hirosawa K; Yatabe Y; Mori N
Pathol Int; 2011 Dec; 61(12):752-5. PubMed ID: 22126384
[TBL] [Abstract][Full Text] [Related]
30. [EBV-associated lymphoproliferative disorders].
Overkamp M; Quintanilla-Martinez L; Fend F
Pathologie (Heidelb); 2022 Jul; 43(4):282-291. PubMed ID: 35925225
[TBL] [Abstract][Full Text] [Related]
31. Differentiation of EBV-induced post-transplant Hodgkin lymphoma from Hodgkin-like post-transplant lymphoproliferative disease.
Rohr JC; Wagner HJ; Lauten M; Wacker HH; Jüttner E; Hanke C; Pohl M; Niemeyer CM
Pediatr Transplant; 2008 Jun; 12(4):426-31. PubMed ID: 18466428
[TBL] [Abstract][Full Text] [Related]
32. [The understanding of Epstein-Barr virus associated lymphoproliferative disorder].
Zhou XG; Zhang YL; Xie JL; Huang YH; Zheng YY; Li WS; Chen H; Liu F; Pan HX; Wei P; Wang Z; Hu YC; Yang KY; Xiao HL; Wu MJ; Yin WH; Mei KY; Chen G; Yan XC; Meng G; Xu G; Li J; Tian SF; Zhu J; Song YQ; Zhang WJ
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):817-821. PubMed ID: 28056294
[TBL] [Abstract][Full Text] [Related]
33. Human herpes virus 8-unrelated primary effusion lymphoma-like lymphoma in the pericardium: A case with latency type III Epstein-Barr virus infection showing good prognosis without chemotherapy.
Nakamura H; Tsuta K; Nakagawa T; Hirai R; Ota Y
Pathol Res Pract; 2015 Dec; 211(12):1010-3. PubMed ID: 26384578
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr virus recruits PDL1-positive cells at the microenvironment in pediatric Hodgkin lymphoma.
Jimenez O; Colli S; Garcia Lombardi M; Preciado MV; De Matteo E; Chabay P
Cancer Immunol Immunother; 2021 Jun; 70(6):1519-1526. PubMed ID: 33184699
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
[TBL] [Abstract][Full Text] [Related]
36. [Association of Hodgkin lymphoma with Epstein-Barr virus in Hungary].
Keresztes K; Bessenyei B; Szöllosi Z; Beck Z; Miltényi Z; Nemes Z; Oláh E; Illés A
Orv Hetil; 2005 Jul; 146(30):1575-82. PubMed ID: 16136734
[TBL] [Abstract][Full Text] [Related]
37. Antiviral treatment of Epstein-Barr virus-associated lymphoproliferations.
Oertel SH; Riess H
Recent Results Cancer Res; 2002; 159():89-95. PubMed ID: 11785848
[TBL] [Abstract][Full Text] [Related]
38. Frequency of epstein-barr virus in classical hodgkin Lymphoma.
Azhar M; Din HU; Muhammad I; Hashmi SN; Akhtar F
J Ayub Med Coll Abbottabad; 2016; 28(2):271-275. PubMed ID: 28718560
[TBL] [Abstract][Full Text] [Related]
39. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.
Fujimoto K; Hatanaka KC; Hatanaka Y; Kasahara I; Yamamoto S; Tsuji T; Nakata M; Takakuwa Y; Haseyama Y; Oyamada Y; Yonezumi M; Suzuki H; Sakai H; Noguchi H; Mori A; Nishihara H; Teshima T; Matsuno Y
Hematol Oncol; 2020 Dec; 38(5):799-807. PubMed ID: 32798315
[TBL] [Abstract][Full Text] [Related]
40. [Factors involved in host-pathogen interaction for the risk of Hodgkin lymphoma induced by Epstein Barr virus].
Torres Espíndola LM; Arellano Galindo J; Velazquez Cruz R; Castillejos López Mde J
Invest Clin; 2013 Sep; 54(3):311-24. PubMed ID: 24354244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
